|
|
|
市場調查報告書
全球末稍血管支架市場:開發平台評估·競爭環境·市場預測(到2017年為止)
Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
| 出版商 |
GlobalData |
| 出版日期 |
2011年11月 |
商品編碼 |
223329 |
| 內容資訊 |
英文 Pages: 94 |
| 價格 |
|
|
全球末稍血管支架市場:開發平台評估·競爭環境·市場預測(到2017年為止) 是由出版商GlobalData在2011年11月所出版的。
這份英文市場調查報告書包含Pages: 94 價格從美金3500起跳。
本報告提供全球末稍血管支架的市場相關分析，整體市場結構與趨勢，種類·主要各國的收益實際成果與預測(2003-2017年)，競爭趨勢，主要產品·企業簡介，彙整以上種種資訊，為您概述為以下內容。
第1章 目錄
第2章 簡介
第3章 疾病概要
第4章 設備概要
- 大腿膝窩動脈支架
- 髂骨動脈支架
- 腎臟動脈支架
- 頸動脈支架
- 膝窩下動脈支架
第5章 市場特徵
- 市場收益實際成果值(全球，2003-2010年)
- 市場收益預測值(全球，2010-2017年)
- 市場動態:推動及阻礙市場要素
第6章 各部門分析
- 大腿膝窩動脈支架:市場收益實際成果值(2003-2010年)
- 大腿膝窩動脈支架:市場收益預測值(2010-2017年)
- 大腿膝窩動脈支架:市場動態(推動及阻礙市場要素)
- 髂骨動脈支架:市場收益實際成果值(2003-2010年)
- 髂骨動脈支架:市場收益預測值(2010-2017年)
- 髂骨動脈支架:市場動態(推動及阻礙市場要素)
- 腎臟動脈支架:市場收益實際成果值(2003-2010年)
- 腎臟動脈支架:市場收益預測值(2010-2017年)
- 腎臟動脈支架:市場動態(推動及阻礙市場要素)
- 頸動脈支架:市場收益實際成果值(2003-2010年)
- 頸動脈支架:市場收益預測值(2010-2017年)
- 頸動脈支架:市場動態(推動及阻礙市場要素)
- 膝窩下動脈支架:市場收益實際成果值(2003-2010年)
- 膝窩下動脈支架:市場收益預測值(2010-2017年)
- 膝窩下動脈支架:市場動態(推動及阻礙市場要素)
第7章 各國的市場收益實際成果值·預測值(2003-2017年)
- 市場收益實際成果值:美國(2003-2010年)
- 市場收益預測值:美國(2010-2017年)
- 市場收益實際成果值:加拿大(2003-2010年)
- 市場收益預測值:加拿大(2010-2017年)
- 市場收益實際成果值:英國(2003-2010年)
- 市場收益預測值:英國(2010-2017年)
- 市場收益實際成果值:法國(2003-2010年)
- 市場收益預測值:法國(2010-2017年)
- 市場收益實際成果值:德國(2003-2010年)
- 市場收益預測值:德國(2010-2017年)
- 市場收益實際成果值:義大利(2003-2010年)
- 市場收益預測值:義大利(2010-2017年)
- 市場收益實際成果值:西班牙(2003-2010年)
- 市場收益預測值:西班牙(2010-2017年)
- 市場收益實際成果值:日本(2003-2010年)
- 市場收益預測值:日本(2010-2017年)
- 市場收益實際成果值:中國(2003-2010年)
- 市場收益預測值:中國(2010-2017年)
- 市場收益實際成果值:印度(2003-2010年)
- 市場收益預測值:印度(2010-2017年)
- 市場收益實際成果值:澳洲(2003-2010年)
- 市場收益預測值:澳洲(2010-2017年)
- 市場收益實際成果值:巴西(2003-2010年)
- 市場收益預測值:巴西(2010-2017年)
第8章 競爭力評估
- 企業佔有率(全球，2010年)
- 外部的因素分析(機會·威脅)
- Cordis Corporation:概要，市售產品
- Abbott Vascular, Inc.:概要，市售產品
- Boston Scientific:概要，市售產品
- C.R.Bard, Inc:概要，市售產品
- Covidien Plc (ev3 Inc):概要，市售產品
第9章 策略性開發平台評估
- 產品平台分析
- 末梢血管支架:開發中產品概要
- 臨床實驗中的潛力產品簡介
- ZILVER PTX Drug Eluting Peripheral Stent
- LifeJacket Stent Graft-PERIF
- BioMimics 3D Stent
- Bioresorbable Peripheral Stent
- Assurant Cobalt Iliac Stent
- Periteneum-Lined Balloon-Expandable Stent
- Absolute Pro Peripheral Self-Expanding Stent System
第10章 資本交易環境
- 主要的企業合併·收購活動(2010年第一季-2011年第2季)
- 主要的夥伴關係(2010年第一季-2011年第2季)
第11章 附錄
圖表一覽
Abstract
Summary
GlobalData's new report, "Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global peripheral vascular stents market. The report provides market landscape, competitive landscape and market trends information on the peripheral vascular stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Fem-pop Stents, Iliac Artery Stents, Renal Stents, Carotid Artery Stents and Infrapop Stents.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the peripheral vascular stents market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Cordis Corporation, Abbott Vascular, Boston Scientific Corporation, C.R.Bard, Inc. and Covidien (ev3).
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the peripheral vascular stents market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the peripheral vascular stents market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global peripheral vascular stents market and the factors shaping it.
Table of Contents
1. Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2. Introduction
- 2.1 GlobalData Report Guidance
3. Disease Overview
- 3.1 Peripheral Vascular Disease
- 3.1.1 Etiology and Risk Factors
- 3.1.2 Pathophysiology
- 3.1.3 Peripheral Vascular Stents, Treatment Flow Model
4. Device Overview
- 4.1 Fem-pop Stents
- 4.2 Iliac Artery Stents
- 4.3 Renal Artery Stents
- 4.4 Carotid Artery Stents
- 4.5 Infra-pop Stents
5. Peripheral Vascular Stents - Market Characterization
- 5.1 Peripheral Vascular Stents Market, Global, Revenue ($bn), Historic, 2003-2010
- 5.2 Peripheral Vascular Stents Market, Global, Revenue ($bn), Forecast, 2010-2017
- 5.3 Peripheral Vascular Stents, Market Dynamics
- 5.3.1 Market Drivers
- 5.3.2 Market Restraints
6. Peripheral Vascular Stents - Market Segment Analysis
- 6.1 Fem-pop Stents Market, Global, Revenue ($m), Historic, 2003-2010
- 6.2 Fem-pop Stents Market, Global, Revenue ($m), Forecast, 2010-2017
- 6.3 Fem-pop Stents, Market Dynamics
- 6.3.1 Market Drivers
- 6.3.2 Market Restraint
- 6.4 Iliac Artery Stents Market, Global, Revenue ($m), Historic, 2003-2010
- 6.5 Iliac Artery Stents Market, Global, Revenue ($m), Forecast, 2010-2017
- 6.6 Iliac Artery Stents, Market Dynamics
- 6.6.1 Market Driver
- 6.6.2 Market Restraint
- 6.7 Renal Artery Stents Market, Global, Revenue ($m), Historic, 2003-2010
- 6.8 Renal Artery Stents Market, Global, Revenue ($m), Forecast, 2010-2017
- 6.9 Renal Stents, Market Dynamics
- 6.9.1 Market Driver
- 6.9.2 Market Restraint
- 6.10 Carotid Artery Stents Market, Global, Revenue ($m), Historic, 2003-2010
- 6.11 Carotid Artery Stents Market, Global, Revenue ($m), Forecast, 2010-2017
- 6.12 Carotid Artery Stents, Market Dynamics
- 6.12.1 Market Drivers
- 6.12.2 Market Restraints
- 6.13 Infra-pop Stents Market, Global, Revenue ($m), Historic, 2003-2010
- 6.14 Infra-pop Stents Market, Global, Revenue ($m), Forecast, 2010-2017
- 6.15 Infra-pop Stents, Market Dynamics
- 6.15.1 Market Drivers
- 6.15.2 Market Restraint
7. Peripheral Vascular Stents Market, by Country, Revenue ($m), 2003-2017
- 7.1 Peripheral Vascular Stents Market, the US, Revenue ($m), by Segment, Historic, 2003-2010
- 7.2 Peripheral Vascular Stents Market, the US, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.3 Peripheral Vascular Stents Market, Canada, Revenue ($m), by Segment, Historic, 2003-2010
- 7.4 Peripheral Vascular Stents Market, Canada, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.5 Peripheral Vascular Stents Market, the UK, Revenue ($m), by Segment, Historic, 2003-2010
- 7.6 Peripheral Vascular Stents Market, the UK, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.7 Peripheral Vascular Stents Market, Germany, Revenue ($m), by Segment, Historic, 2003-2010
- 7.8 Peripheral Vascular Stents Market, Germany, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.9 Peripheral Vascular Stents Market, France, Revenue ($m), by Segment, Historic, 2003-2010
- 7.10 Peripheral Vascular Stents Market, France, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.11 Peripheral Vascular Stents Market, Italy, Revenue ($m), by Segment, Historic, 2003-2010
- 7.12 Peripheral Vascular Stents Market, Italy, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.13 Peripheral Vascular Stents Market, Spain, Revenue ($m), by Segment, Historic, 2003-2010
- 7.14 Peripheral Vascular Stents Market, Spain, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.15 Peripheral Vascular Stents Market, Japan, Revenue ($m), by Segment, Historic, 2003-2010
- 7.16 Peripheral Vascular Stents Market, Japan, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.17 Peripheral Vascular Stents Market, China, Revenue ($m), by Segment, Historic, 2003-2010
- 7.18 Peripheral Vascular Stents Market, China, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.19 Peripheral Vascular Stents Market, India, Revenue ($m), by Segment, Historic, 2003-2010
- 7.20 Peripheral Vascular Stents Market, India, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.21 Peripheral Vascular Stents Market, Australia, Revenue ($m), by Segment, Historic, 2003-2010
- 7.22 Peripheral Vascular Stents Market, Australia, Revenue ($m), by Segment, Forecast, 2010-2017
- 7.23 Peripheral Vascular Stents Market, Brazil, Revenue ($m), by Segment, Historic, 2003-2010
- 7.24 Peripheral Vascular Stents Market, Brazil, Revenues ($m), by Segment, Forecast, 2010-2017
8. Peripheral Vascular Stents - Competitive Assessment
- 8.1 Peripheral Vascular Stents Market, Global, Company Share (%), 2010
- 8.2 Peripheral Vascular Stents Market, External Factors Analysis
- 8.2.1 Opportunities
- 8.2.2 Threats
- 8.3 Cordis Corporation
- 8.3.1 Overview
- 8.3.2 Marketed Products in Peripheral Vascular Stents
- 8.4 Abbott Vascular, Inc.
- 8.4.1 Overview
- 8.4.2 Marketed Products
- 8.5 Boston Scientific
- 8.5.1 Overview
- 8.5.2 Marketed Products in Peripheral Vascular Stents
- 8.6 C.R.Bard, Inc
- 8.6.1 Overview
- 8.6.2 Marketed Products
- 8.7 Covidien Plc (ev3 Inc)
- 8.7.1 Overview
- 8.7.2 Marketed Products in Peripheral Vascular Stents
9. Peripheral Vascular Stents Market - Strategic Pipeline Assessment
- 9.1 Product Pipeline Analysis
- 9.2 Peripheral Vascular Stents: Pipeline Products Summary
- 9.3 Profiles of Promising Products under Clinical Development
- 9.3.1 ZILVER PTX Drug Eluting Peripheral Stent
- 9.3.2 LifeJacket Stent Graft-PERIF
- 9.3.3 BioMimics 3D Stent
- 9.3.4 Bioresorbable Peripheral Stent
- 9.3.5 Assurant Cobalt Iliac Stent
- 9.3.6 Periteneum-Lined Balloon-Expandable Stent
- 9.3.7 Absolute Pro Peripheral Self-Expanding Stent System
10. Peripheral Vascular Stents Market - Deals Landscape
- 10.1 Key Mergers and Acquisitions (First Quarter 2010 to Second Quarter 2011)
- 10.1.1 Covidien Completes Acquisition of ev3 for $2.6 billion
- 10.1.2 C. R. Bard Completes Acquisition of FlowCardia
- 10.1.3 Degania Silicone Completes Acquisition of Arthesys
- 10.1.4 Medtronic Completes Acquisition of Invatec and Affiliated Companies
- 10.2 Key Partnerships (First Quarter 2010 to Second Quarter 2011)
- 10.2.1 Cordis Enters Into Distribution Agreement with Ostial Solutions
- 10.2.2 Endologix Enters Into an Agreement with Evasc Medical Systems
11. Appendix
- 11.1 Definitions
- 11.1.1 Peripheral Vascular Stents
- 11.2 Acronyms
- 11.3 Research Methodology
- 11.4 Secondary Research
- 11.5 Primary Research
- 11.6 Models
- 11.7 Forecasts
- 11.8 Expert Panels
- 11.9 GlobalData Consulting
- 11.10 Contact Us
- 11.11 Disclaimer
- 11.12 Sources
List of Tables
- Table 1: Peripheral Vascular Stents Market, Global, Revenue ($bn), 2003-2010
- Table 2: Peripheral Vascular Stents Market, Global, Revenue ($bn), 2010-2017
- Table 3: Lower Extremity Peripheral Angioplasty Procedures, the US, 1996-2006
- Table 4: Prevalence of Peripheral Vascular Disease by Age Group, the US
- Table 5: Population Aged Above 60 as a Percentage of Total Population, Global, 2010-2030
- Table 6: Number of Smokers, Global, 2006-2025
- Table 7: Prevalence of Diabetes (%), Global, 2010-2030
- Table 8: Fem-pop Stents Market, Global, Revenue ($m), 2003-2010
- Table 9:Fem-pop Stents Market, Global, Revenue ($m), 2010-2017
- Table 10: New SFA Stents by Company, Global, 2010
- Table 11: Two Year Follow-up Results of Zilver PTX Trial
- Table 12: Iliac Artery Stents Market, Global, Revenue ($m), 2003-2010
- Table 13: Iliac Artery Stents Market, Global, Revenue ($m), 2010-2017
- Table 14: Renal Artery Stents Market, Global, Revenue ($m), 2003-2010
- Table 15: Renal Stents Market, Global, Revenue ($m), 2010-2017
- Table 16: Results of ASTRAL trial
- Table 17: Carotid Artery Stents Market, Global, Revenue ($m), 2003-2010
- Table 18: Carotid Artery Stents Market, Global, Revenue ($m), 2010-2017
- Table 19: Results of CREST Trial
- Table 20: 30 Day Follow-up Results of EVA-3S Trial
- Table 21: 120 Day Safety Analysis of ICSS Trial
- Table 22: Infra-pop Stents Market, Global, Revenue ($m), 2003-2010
- Table 23: Infra-pop Stents Market, Global, Revenue ($m), 2010-2017
- Table 24: ACHILLES Trials - 12 month in-segment Binary Restenosis
- Table 25: DESTINY Trials - 12 month Results
- Table 26: Peripheral Vascular Stents Market, the US, Revenue ($m), 2003-2010
- Table 27: Peripheral Vascular Stents Market, the US, Revenue ($m), 2010-2017
- Table 28: Peripheral Vascular Stents Market, Canada, Revenue ($m), 2003-2010
- Table 29: Peripheral Vascular Stents Market, Canada, Revenue ($m), 2010-2017
- Table 30: Peripheral Vascular Stents Market, the UK, Revenue ($m), 2003-2010
- Table 31: Peripheral Vascular Stents Market, the UK, Revenue ($m), 2010-2017
- Table 32: Peripheral Vascular Stents Market, Germany, Revenue ($m), 2003-2010
- Table 33: Peripheral Vascular Stents Market, Germany, Revenue ($m), 2010-2017
- Table 34: Peripheral Vascular Stents Market, France, Revenue ($m), 2003-2010
- Table 35: Peripheral Vascular Stents Market, France, Revenue ($m), 2010-2017
- Table 36: Peripheral Vascular Stents Market, Italy, Revenue ($m), 2003-2010
- Table 37: Peripheral Vascular Stents Market, Italy, Revenue ($m), 2010-2017
- Table 38: Peripheral Vascular Stents Market, Spain, Revenue ($m), 2003-2010
- Table 39: Peripheral Vascular Stents Market, Spain, Revenue ($m), 2010-2017
- Table 40: Peripheral Vascular Stents Market, Japan, Revenue ($m), 2003-2010
- Table 41: Peripheral Vascular Stents Market, Japan, Revenue ($m), 2010-2017
- Table 42: Peripheral Vascular Stents Market, China, Revenue ($m), 2003-2010
- Table 43: Peripheral Vascular Stents Market, China, Revenue ($m), 2010-2017
- Table 44: Peripheral Vascular Stents Market, India, Revenue ($m), 2003-2010
- Table 45: Peripheral Vascular Stents Market, India, Revenue ($m), 2010-2017
- Table 46: Peripheral Vascular Stents Market, Australia, Revenue ($m), 2003-2010
- Table 47: Peripheral Vascular Stents Market, Australia, Revenue ($m), 2010-2017
- Table 48: Peripheral Vascular Stents Market, Brazil, Revenue ($m), 2003-2010
- Table 49: Peripheral Vascular Stents Market, Brazil, Revenue ($m), 2010-2017
- Table 50: Peripheral Vascular Stents Market, Global, Company Revenue ($m), 2010
- Table 51: Key Marketed Products, Peripheral Vascular Stents, Cordis Corporation
- Table 52: Key Marketed Products, Peripheral Vascular Stents, Abbott Vascular
- Table 53: Key Marketed Products, Peripheral Vascular Stents, Boston Scientific
- Table 54: Key Marketed Products, Peripheral Vascular Stents, C.R.Bard Inc
- Table 55: Key Marketed Products, Peripheral Vascular Stents Market, Covidien Inc.
- Table 56: Peripheral Vascular Stents: Pipeline Products Summary
- Table 57: ZILVER PTX Drug Eluting Peripheral Stent, Product Status, 2011
- Table 58: ZILVER PTX Drug Eluting Peripheral Stent, Clinical Trial 1, 2011
- Table 59: ZILVER PTX Drug Eluting Peripheral Stent, Clinical Trial 2, 2011
- Table 60: LifeJacket Stent Graft-PERIF, Product Status, 2011
- Table 61: BioMimics 3D Stent, Product Status, 2011
- Table 62: Bioresorbable Peripheral Stent, Product Status, 2011
- Table 63: Assurant Cobalt Iliac Stent System, Product Status, 2011
- Table 64: Assurant Cobalt Iliac Stent System, Clinical Trial
- Table 65: Periteneum-Lined Balloon - Expandable Stent, Product Status, 2011
- Table 66: Absolute Pro Peripheral Self-Expanding Stent System, Product Status, 2011
- Table 67: Absolute Pro Peripheral Self-Expanding Stent System , Clinical Trial, 2011
List of Figures
- Figure 1: Peripheral Vascular Stents, Treatment Flow Model, Global, 2010
- Figure 2: Peripheral Vascular Stents, Market Segmentation
- Figure 3: Peripheral Vascular Stents Market, Global, Revenue ($bn), 2003-2010
- Figure 4: Peripheral Vascular Stents Market, Global, Revenue ($bn), 2010-2017
- Figure 5: Lower Extremity Peripheral Angioplasty Procedures Growth, the US, 1996-2006
- Figure 6: Prevalence of Peripheral Vascular Disease by Age Group, the US
- Figure 7: Population Aged Above 60 As Percentage of Total Population, Global, 2010-2030
- Figure 8: Number of Smokers (billion), Global, 2006-2025
- Figure 9: Prevalence of Diabetes (%), Global, 2010-2030
- Figure 10: Treatment Seeking Population, Peripheral Vascular Disease
- Figure 11: Fem-pop Stents Market, Global, Revenue ($m), 2003-2010
- Figure 12: Fem-pop Stents Market, Global, Revenue ($m), 2010-2017
- Figure 13: Iliac Artery Stents Market, Global, Revenue ($m), 2003-2010
- Figure 14: Iliac Artery Stents Market, Global, Revenue ($m), 2010-2017
- Figure 15: Self Expandable vs Balloon Expandable Stent in Iliac Artery Stenting
- Figure 16: Renal Artery Stents Market, Global, Revenue ($m), 2003-2010
- Figure 17: Renal Artery Stents Market, Global, Revenue ($m), 2010-2017
- Figure 18: Carotid Artery Stents Market, Global, Revenue ($m), 2003-2010
- Figure 19: Carotid Artery Stents Market, Global, Revenue ($m), 2010-2017
- Figure 20: Infra-pop Stents Market, Global, Revenue ($m), 2003-2010
- Figure 21: Infra-pop Stents Market, Global, Revenue ($m), 2010-2017
- Figure 22: Peripheral Vascular Stents Market, the US, Revenue ($m), 2003-2010
- Figure 23: Peripheral Vascular Stents Market, the US, Revenue ($m), 2010-2017
- Figure 24: Peripheral Vascular Stents Market, Canada, Revenue ($m), 2003-2010
- Figure 25: Peripheral Vascular Stents Market, Canada, Revenue ($m), 2010-2017
- Figure 26: Peripheral Vascular Stents Market, the UK, Revenue ($m), 2003-2010
- Figure 27: Peripheral Vascular Stents Market, the UK, Revenue ($m), 2010-2017
- Figure 28: Peripheral Vascular Stents Market, Germany, Revenue($m), 2003-2010
- Figure 29: Peripheral Vascular Stents Market, Germany, Revenue ($m), 2010-2017
- Figure 30: Peripheral Vascular Stents Market, France, Revenue ($m), 2003-2010
- Figure 31: Peripheral Vascular Stents Market, France, Revenue ($m), 2010-2017
- Figure 32: Peripheral Vascular Stents Market, Italy, Revenue ($m), 2003-2010
- Figure 33: Peripheral Vascular Stents Market, Italy, Revenue ($m), 2010-2017
- Figure 34: Peripheral Vascular Stents Market, Spain, Revenue ($m), 2003-2010
- Figure 35: Peripheral Vascular Stents Market, Spain, Revenue ($m), 2010-2017
- Figure 36: Peripheral Vascular Stents Market, Japan, Revenue ($m), 2003-2010
- Figure 37: Peripheral Vascular Stents Market, Japan, Revenue ($m), 2010-2017
- Figure 38: Peripheral Vascular Stents Market, China, Revenue ($m), 2003-2010
- Figure 39: Peripheral Vascular Stents Market, China, Revenue ($m), 2010-2017
- Figure 40: Peripheral Vascular Stents Market, India, Revenue ($m), 2003-2010
- Figure 41: Peripheral Vascular Stents Market, India, Revenue ($m), 2010-2017
- Figure 42: Peripheral Vascular Stents Market, Australia, Revenue ($m), 2003-2010
- Figure 43: Peripheral Vascular Stents Market, Australia, Revenue ($m), 2010-2017
- Figure 44: Peripheral Vascular Stents Market, Brazil, Revenue ($m), 2003-2010
- Figure 45: Peripheral Vascular Stents Market, Brazil, Revenue ($m), 2010-2017
- Figure 46: Peripheral Vascular Stents Market, Global, Company Share (%), 2010
- Figure 47: External Factors Affecting the Peripheral Vascular Stents Companies
- Figure 48: Peripheral Vascular Stents, Product Pipeline Analysis, Global, 2010
|
 |
